共找到 4 份报告搜索:GLP-1激动剂

Pakistan's Advantage in Hepatitis Delta & MASH Trials

IQVIA2026-01-0216

Insights into Clinical Trial Enrollment for MASH with Compensated Cirrhosis

IQVIA2026-07-1616